Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $552M (100.0% shares, 0.0% debt)

Holdings (21)

ALMS ALUMIS INC 12.8%

Value $70.54M Shares 3,202,075 Est. Cost $7.34 Unrealized +231.4%

AMLX AMYLYX PHARMACEUTICALS INC 10.9%

Value $60.46M Shares 4,349,885 Est. Cost $5.73 Unrealized +144.3%

ABVX ABIVAX SA 10.9%

Value $60.43M Shares 542,696 Est. Cost $29.41 Unrealized —

PCVX VAXCYTE INC 8.7%

Value $47.91M Shares 824,532 Est. Cost $44.25 Unrealized +19.2%

PHVS PHARVARIS N V 6.1%

Value $33.94M Shares 1,201,402 Est. Cost $22.82 Unrealized +17.2%

IMMX IMMIX BIOPHARMA INC 6.1%

Value $33.65M Shares 3,693,585 Est. Cost $4.51 Unrealized +37.4%

CELC CELCUITY INC 5.8%

Value $32.18M Shares 281,904 Est. Cost $15.84 Unrealized +578.4%

JAZZ JAZZ PHARMACEUTICALS PLC 5.6%

Value $30.81M Shares 162,961 Est. Cost $112.15 Unrealized +50.7%

IRON DISC MEDICINE INC 5.2%

Value $28.77M Shares 449,926 Est. Cost $56.75 Unrealized +30.5%

XFOR X4 PHARMACEUTICALS INC 4.8%

Value $26.67M Shares 6,456,646 Est. Cost $3.63 Unrealized +0.1%

COGT COGENT BIOSCIENCES INC 4.4%

Value $24.12M Shares 626,635 Est. Cost $7.59 Unrealized +392.1%

MNPR MONOPAR THERAPEUTICS INC 3.4%

Value $18.94M Shares 345,626 Est. Cost $63.98 Unrealized -1.9%

DYN DYNE THERAPEUTICS INC 3.2%

Value $17.52M Shares 966,609 Est. Cost $11.19 Unrealized +53.0%

IVVD INVIVYD INC 2.6%

Value $14.23M Shares 10,949,084 Est. Cost $2.05 Unrealized -3.5%

CADL CANDEL THERAPEUTICS INC 2.6%

Value $14.19M Shares 2,896,588 Est. Cost $5.74 Unrealized 0.0%

OCS OCULIS HOLDING AG 2.5%

Value $13.74M Shares 516,761 Est. Cost $20.00 Unrealized +32.4%

OVID OVID THERAPEUTICS INC 1.7%

Value $9.25M Shares 4,166,666 Est. Cost $1.56 Unrealized +2.1%

IKT INHIBIKASE THERAPEUTICS INC 1.2%

Value $6.491M Shares 3,863,445 Est. Cost $1.59 Unrealized +9.0%

ZURA ZURA BIO LTD 0.8%

Value $4.403M Shares 739,960 Est. Cost $5.88 Unrealized 0.0%

ANRO ALTO NEUROSCIENCE INC 0.4%

Value $2.001M Shares 88,999 Est. Cost $16.77 Unrealized 0.0%

MSLE SATELLOS BIOSCIENCE INC 0.4%

Value $1.97M Shares 350,000 Est. Cost $5.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC	3,202,075	$70.54M	12.8%	$7.34	+231.4%	COM	022307102
AMLX	AMYLYX PHARMACEUTICALS INC	4,349,885	$60.46M	10.9%	$5.73	+144.3%	COM	03237H101
ABVX	ABIVAX SA	542,696	$60.43M	10.9%	$29.41	—	SPONSORED ADS	00370M103
PCVX	VAXCYTE INC	824,532	$47.91M	8.7%	$44.25	+19.2%	COM	92243G108
PHVS	PHARVARIS N V	1,201,402	$33.94M	6.1%	$22.82	+17.2%	COM	N69605108
IMMX	IMMIX BIOPHARMA INC	3,693,585	$33.65M	6.1%	$4.51	+37.4%	COM	45258H106
CELC	CELCUITY INC	281,904	$32.18M	5.8%	$15.84	+578.4%	COM	15102K100
JAZZ	JAZZ PHARMACEUTICALS PLC	162,961	$30.81M	5.6%	$112.15	+50.7%	SHS USD	G50871105
IRON	DISC MEDICINE INC	449,926	$28.77M	5.2%	$56.75	+30.5%	COM	254604101
XFOR	X4 PHARMACEUTICALS INC	6,456,646	$26.67M	4.8%	$3.63	+0.1%	COM NEW	98420X202
COGT	COGENT BIOSCIENCES INC	626,635	$24.12M	4.4%	$7.59	+392.1%	COM	19240Q201
MNPR	MONOPAR THERAPEUTICS INC	345,626	$18.94M	3.4%	$63.98	-1.9%	COM NEW	61023L207
DYN	DYNE THERAPEUTICS INC	966,609	$17.52M	3.2%	$11.19	+53.0%	COM	26818M108
IVVD	INVIVYD INC	10,949,084	$14.23M	2.6%	$2.05	-3.5%	COM	00534A102
CADL	CANDEL THERAPEUTICS INC	2,896,588	$14.19M	2.6%	$5.74	0.0%	COM	137404109
OCS	OCULIS HOLDING AG	516,761	$13.74M	2.5%	$20.00	+32.4%	ORDINARY SHARES	H5870P102
OVID	OVID THERAPEUTICS INC	4,166,666	$9.25M	1.7%	$1.56	+2.1%	COM	690469101
IKT	INHIBIKASE THERAPEUTICS INC	3,863,445	$6.491M	1.2%	$1.59	+9.0%	COM NEW	45719W205
ZURA	ZURA BIO LTD	739,960	$4.403M	0.8%	$5.88	0.0%	CLASS A ORD SHS	G9TY5A101
ANRO	ALTO NEUROSCIENCE INC	88,999	$2.001M	0.4%	$16.77	0.0%	COM SHS	02157Q109
MSLE	SATELLOS BIOSCIENCE INC	350,000	$1.97M	0.4%	$5.63	—	COM	80401L803